MENDLEIN JOHN 4
4 · FATE THERAPEUTICS INC · Filed Jan 20, 2023
Insider Transaction Report
Form 4
MENDLEIN JOHN
Director
Transactions
- Exercise/Conversion
Common Stock
2023-01-19$1.37/sh+28,461$38,992→ 311,231 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-01-19+28,461→ 0 totalExercise: $1.37Exp: 2023-02-06→ Common Stock (28,461 underlying)
Footnotes (1)
- [F1]This stock option is fully vested and exercisable.